Beat A Schaer
Overview
Explore the profile of Beat A Schaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Theuns D, Niazi K, Schaer B, Sticherling C, Yap S, Caliskan K
J Cardiovasc Electrophysiol
. 2021 Apr;
32(6):1687-1694.
PMID: 33825257
Introduction: Cardiac resynchronization defibrillator (CRT-D) as primary prevention is known to reduce mortality. At the time of replacement, higher age and comorbidities may attenuate the benefit of implantable cardioverter-defibrillator (ICD)...
2.
Theuns D, Schaer B, Caliskan K, Hoeks S, Sticherling C, Yap S, et al.
Int J Cardiol
. 2021 Jan;
330:73-79.
PMID: 33516838
Background: The Heart Failure (HF) Meta-score may be useful in predicting prognosis in patients with primary prevention cardiac resynchronization defibrillators (CRT-D) considering the competing risk of appropriate defibrillator shock versus...
3.
Reichlin T, Asatryan B, Vos M, Willems R, Huikuri H, Junttila M, et al.
Heart Rhythm
. 2020 May;
17(10):1664-1671.
PMID: 32428669
Background: Myocardial scarring from infarction or nonischemic fibrosis forms an arrhythmogenic substrate. The Selvester QRS score has been developed to estimate myocardial scar from the 12-lead electrocardiogram. Objective: We aimed...
4.
Theuns D, van Boven N, Schaer B, Hesselink T, Rivero-Ayerza M, Umans V, et al.
J Card Fail
. 2019 Sep;
25(10):812-818.
PMID: 31479745
Background: The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have clearly been established. Nevertheless, mortality...
5.
Sticherling C, Muller D, Schaer B, Kruger S, Kolb C
Indian Pacing Electrophysiol J
. 2018 Mar;
18(4):140-145.
PMID: 29596906
Methods And Results: Seventeen patients (16 males, mean age 73 ± 6 years, mean EF 25 ± 5%) with permanent AF and an indication for CRT-defibrillator placement were implanted with...
6.
Sticherling C, Arendacka B, Svendsen J, Wijers S, Friede T, Stockinger J, et al.
Europace
. 2017 Oct;
20(6):963-970.
PMID: 29016784
Aims: Therapy with an implantable cardioverter defibrillator (ICD) is established for the prevention of sudden cardiac death (SCD) in high risk patients. We aimed to determine the effectiveness of primary...
7.
Akoudad S, Dabiri Abkenari L, Schaer B, Sticherling C, Levy W, Jordaens L, et al.
Am J Cardiol
. 2017 Mar;
119(9):1414-1420.
PMID: 28267958
Several multivariate risk score models were developed to predict prognosis of patients with heart failure (HF). We compared 3 models with regard to prediction of mortality in patients with HF...
8.
Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
Gunten S, Schaer B, Yap S, Szili-Torok T, Kuhne M, Sticherling C, et al.
Europace
. 2015 Nov;
18(5):710-7.
PMID: 26609076
Aims: Longevity of implantable cardioverter defibrillators (ICDs) is crucial for patients and healthcare systems as replacements impact on infection rates and cost-effectiveness. Aim was to determine longevity using very large...
9.
Vischer A, Mutschelknauss M, Kuhne M, Osswald S, Sticherling C, Schaer B
Pacing Clin Electrophysiol
. 2015 Apr;
38(7):864-9.
PMID: 25850523
Background: Many patients receiving an implantable cardioverter-defibrillator (ICD) also have atrial fibrillation (AF). Shock testing during ICD implantation carries a potential risk of cardioversion to sinus rhythm (SR) and thrombembolic...
10.
Yap S, Schaer B, Bhagwandien R, Kuhne M, Dabiri Abkenari L, Osswald S, et al.
Heart
. 2014 Jul;
100(15):1188-92.
PMID: 24993502
Objective: It is not clear whether patients who received an implantable cardioverter-defibrillator (ICD) for primary prevention should undergo device replacement if they never experienced an appropriate ICD therapy during the...